Clinical Trial

Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of Olostar Tablet on blood pressure and lipid profiles, obtain safety-related information for subgroups that failed to participate in the clinical trials, and to evaluate variables that affect treatment effectiveness.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-06-06; most recent amendment 2025-08-22.
Status change: Recruiting → Active, Not Recruiting 2024-07-01
Status change: Not Yet Recruiting → Recruiting 2023-05-24
Trial Details
NCT Number NCT05411887
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Hyperlipidemias, Hypertension
Enrollment 2,845 participants
Start Date 2022-06-20
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-24